While this work undermines the prospects of Bcl-2 rG4 as an anti-tumor therapy target, it raised important questions about the adequacy of primary DLR and in vitro translation methods for assessing rG4’s influence on translation efficiency. This evidence concerns the gene UNC119 and neoplasm.